Corza medical signs definitive agreement to acquire takeda's tachosil manufacturing operations

Westwood, mass., april 26, 2023 (globe newswire) -- corza medical announced today that it has entered into a definitive agreement with a subsidiary of takeda pharmaceuticals company (tse:4502/nyse:tak) (“takeda”) to acquire the tachosil manufacturing operations in linz, austria. corza medical had previously acquired the commercial product rights for tachosil, a best-in-class surgical patch trusted by medical professionals worldwide, in january 2021. corza medical shares takeda's commitment to patient care and has the experience and resources to continue investing in tachosil for the benefit of patients. 
TAK Ratings Summary
TAK Quant Ranking